ADME properties evaluation in drug discovery: in silico prediction of blood–brain partitioning
暂无分享,去创建一个
Yadong Chen | Yuanrong Fan | Yanmin Zhang | Junnan Zhao | Weineng Zhou | Haichun Liu | Yanmin Zhang | Yadong Chen | Lu Zhu | Linfeng Yin | Yuchen Wang | Haichun Liu | Weineng Zhou | Lu Zhu | Junnan Zhao | Yuchen Wang | Yuanrong Fan | Linfeng Yin
[1] Junmei Wang,et al. Applications of genetic algorithms on the structure–activity correlation study of a group of non-nucleoside HIV-1 inhibitors , 1999 .
[2] Alexander Golbraikh,et al. QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds , 2008, Pharmaceutical Research.
[3] Ramamurthi Narayanan,et al. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.
[4] M. Jalali-Heravi,et al. Quantitative structure-activity relationship study of serotonin (5-HT7) receptor inhibitors using modified ant colony algorithm and adaptive neuro-fuzzy interference system (ANFIS). , 2009, European journal of medicinal chemistry.
[5] Jahan B Ghasemi,et al. Application of principal component analysis-multivariate adaptive regression splines for the simultaneous spectrofluorimetric determination of dialkyltins in micellar media. , 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[6] Scott D. Kahn,et al. Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.
[7] Miguel A. Cabrera,et al. TOPS-MODE approach for the prediction of blood-brain barrier permeation. , 2004, Journal of pharmaceutical sciences.
[8] M. Kansy,et al. Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).
[9] Denis M. Bayada,et al. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.
[10] Liping Lu,et al. Effects of triazole fungicides on androgenic disruption and CYP3A4 enzyme activity. , 2017, Environmental pollution.
[11] Franco Lombardo,et al. A recursive-partitioning model for blood–brain barrier permeation , 2005, J. Comput. Aided Mol. Des..
[12] Hongmao Sun,et al. A Universal Molecular Descriptor System for Prediction of LogP, LogS, LogBB, and Absorption , 2004, J. Chem. Inf. Model..
[13] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[14] C. Fong. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. , 2014, European journal of medicinal chemistry.
[15] U Norinder,et al. Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. , 1998, Journal of pharmaceutical sciences.
[16] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[17] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[18] Roberto Kawakami Harrop Galvão,et al. A method for calibration and validation subset partitioning. , 2005, Talanta.
[19] Maria G. Kouskoura,et al. A new descriptor via bio‐mimetic chromatography and modeling for the blood brain barrier (Part II) , 2019, Journal of pharmaceutical and biomedical analysis.
[20] Alexander Tropsha,et al. Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.
[21] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[22] Bernard Testa,et al. A simple model to predict blood-brain barrier permeation from 3D molecular fields. , 2002, Biochimica et biophysica acta.
[23] S. Walker,et al. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.
[24] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[25] R. Kaliszan,et al. Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands. , 2013, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[26] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[27] Tian-Shyug Lee,et al. Mining the customer credit using classification and regression tree and multivariate adaptive regression splines , 2006, Comput. Stat. Data Anal..
[28] Alexandre Varnek,et al. Correlation of blood-brain penetration using structural descriptors. , 2006, Bioorganic & medicinal chemistry.
[29] X. J. Xu,et al. ADME Evaluation in Drug Discovery. Part 3. Modeling Blood‐Brain Barrier Partitioning Using Simple Molecular Descriptors. , 2004 .
[30] Qingjun Liu,et al. Interactions of benzotriazole UV stabilizers with human serum albumin: Atomic insights revealed by biosensors, spectroscopies and molecular dynamics simulations. , 2016, Chemosphere.
[31] P. Gross,et al. Sensory circumventricular organs and brain homeostatic pathways , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] C. Fong. Permeability of the Blood–Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds , 2015, The Journal of Membrane Biology.
[33] Yizeng Liang,et al. Exploring nonlinear relationships in chemical data using kernel-based methods , 2011 .
[34] Prabha Garg,et al. In Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network Model , 2006, J. Chem. Inf. Model..
[35] Witold R. Rudnicki,et al. Feature Selection with the Boruta Package , 2010 .
[36] Yvan Vander Heyden,et al. Benchmarking of QSAR Models for Blood-Brain Barrier Permeation , 2007, J. Chem. Inf. Model..
[37] Matheus Malta de Sá,et al. A 2D-QSPR approach to predict blood-brain barrier penetration of drugs acting on the central nervous system , 2010 .
[38] A. Ghose,et al. Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .
[39] Chunlong Zhang,et al. Benzotriazole UV 328 and UV-P showed distinct antiandrogenic activity upon human CYP3A4-mediated biotransformation. , 2017, Environmental pollution.
[40] Tingjun Hou,et al. ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors , 2003, J. Chem. Inf. Comput. Sci..
[41] James W. McFarland,et al. Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico‐chemical Parameters , 2000 .
[42] Klaus-Robert Müller,et al. Estimating the domain of applicability for machine learning QSAR models: a study on aqueous solubility of drug discovery molecules , 2007, J. Comput. Aided Mol. Des..
[43] S Agatonovic-Kustrin,et al. Theoretically-derived molecular descriptors important in human intestinal absorption. , 2001, Journal of pharmaceutical and biomedical analysis.
[44] Márcia M. C. Ferreira,et al. Basic validation procedures for regression models in QSAR and QSPR studies: theory and application , 2009 .
[45] Shulin Zhuang,et al. Side Chains of Parabens Modulate Antiandrogenic Activity: In Vitro and Molecular Docking Studies. , 2017, Environmental science & technology.
[46] M. Abraham,et al. A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data. , 2006, Journal of pharmaceutical sciences.
[47] S. Hirono,et al. Simple Method of Calculating Octanol/Water Partition Coefficient. , 1992 .
[48] Thomas Dandekar,et al. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation , 2013, Int. J. Comput. Biol. Drug Des..
[49] Harpreet S. Chadha,et al. Hydrogen-bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. , 1995, Drug design and discovery.